Vyaire Medical Inc. has recalled 2,605 Bellavista 1000 and 1000e series ventilators because of software troubles. The US Food and Drug Administration gave the recall action a high-risk class I designation on 17 February.
The FDA says it has received reports of ventilators “failing to ventilate and generating a technical failure alarm.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?